The Obesity-Susceptibility Gene TMEM18 Promotes Adipogenesis through Activation of PPARG

Summary: TMEM18 is the strongest candidate for childhood obesity identified from GWASs, yet as for most GWAS-derived obesity-susceptibility genes, the functional mechanism remains elusive. We here investigate the relevance of TMEM18 for adipose tissue development and obesity. We demonstrate that adi...

Full description

Bibliographic Details
Published in:	Cell Reports
Main Authors:	Kathrin Landgraf, Nora Klöting, Martin Gericke, Nitzan Maixner, Esther Guiu-Jurado, Markus Scholz, A. Veronica Witte, Frauke Beyer, Julian T. Schwartze, Martin Lacher, Arno Villringer, Peter Kovacs, Assaf Rudich, Matthias Blüher, Wieland Kiess, Antje Körner
Format:	Article
Language:	English
Published:	Elsevier 2020-10-01
Subjects:	TMEM18 adipose progenitor cells adipogenesis PPARG adipose tissue children
Online Access:	http://www.sciencedirect.com/science/article/pii/S2211124720312845

Similar Items

The Role of Peroxisome Proliferator-Activated Receptor Gamma (PPARG) in Adipogenesis: Applying Knowledge from the Fish Aquaculture Industry to Biomedical Research
by: Rebecca Wafer, et al.
Published: (2017-05-01)

Oyster Mushroom (Pleurotus ostreatus) Ethanolic Extract Inhibits Pparg Expression While Maintaining the Methylation of the Pparg Promoter During 3T3-L1 Adipocyte Differentiation
by: Ariyanto EF, et al.
Published: (2025-01-01)

Transcriptional Regulation of Autophagy Genes via Stage-Specific Activation of CEBPB and PPARG during Adipogenesis: A Systematic Study Using Public Gene Expression and Transcription Factor Binding Datasets
by: Mahmoud Ahmed, et al.
Published: (2019-10-01)

In Vitro-Generated Hypertrophic-Like Adipocytes Displaying <i>PPARG</i> Isoforms Unbalance Recapitulate Adipocyte Dysfunctions In Vivo
by: Marianna Aprile, et al.
Published: (2020-05-01)

Dual Modulation of Adipogenesis and Apoptosis by PPARG Agonist Rosiglitazone and Antagonist Betulinic Acid in 3T3-L1 Cells
by: Patsawee Sriboonaied, et al.
Published: (2025-05-01)

The <i>Fabp4</i>-Cre-Model is Insufficient to Study <i>Hoxc9</i> Function in Adipose Tissue
by: Sebastian Dommel, et al.
Published: (2020-06-01)

Inhibition of AHCY impedes proliferation and differentiation of mouse and human adipocyte progenitor cells
by: Paula Boczki, et al.
Published: (2024-12-01)

Perivascular adipose tissue dysfunction contributes to thoracic aortic aneurysm development
by: Zhenguo Wang, et al.
Published: (2025-05-01)

Effects of a PPARG gene variant on obesity characteristics in Brazil
by: V.S. Mattevi, et al.
Published: (2007-07-01)

Integrated Analysis of the Expression Characteristics, Prognostic Value, and Immune Characteristics of PPARG in Breast Cancer
by: Jianbin Wu, et al.
Published: (2021-09-01)

Association between genetically proxied PPARG activation and psoriasis vulgaris: a Mendelian randomization study
by: Yan Xue, et al.
Published: (2024-12-01)

Computational determination of human PPARG gene: SNPs and prediction of their effect on protein functions of diabetic patients
by: Howeida Abdullah Mustafa, et al.
Published: (2020-02-01)

TMEM16 and OSCA/TMEM63 proteins share a conserved potential to permeate ions and phospholipids
by: Augustus J Lowry, et al.
Published: (2024-11-01)

Evaluation of expression levels of NFATc2 and PPARG genes two effector elements of WNT pathway in non-small cell lung carcinoma
by: Kaveh Motamediyan, et al.
Published: (2023-01-01)

Significant association of hyperandrogenism and insulin resistance with the epigenetic alterations in PPARG1 gene in granulosa cells of PCOS females
by: Zahra Dashti, et al.
Published: (2025-06-01)

Association of PPARG and LPIN1 gene polymorphisms with metabolic syndrome and type 2 diabetes
by: Tamer Bego, et al.
Published: (2011-02-01)

Dietary supplementation with long-chain monounsaturated fatty acids attenuates obesity-related metabolic dysfunction and increases expression of PPAR gamma in adipose tissue in type 2 diabetic KK-A<sup>y</sup> mice
by: Yang Zhi-Hong, et al.
Published: (2013-01-01)

Adipose Tissue Development Relies on Coordinated Extracellular Matrix Remodeling, Angiogenesis, and Adipogenesis
by: Elizabeth K. Johnston, et al.
Published: (2022-09-01)

Differences between Aqueous Humor and Serum Concentrations of BDNF and PPARG Genetic Variants in Glaucoma Patients
by: Tena Križ, et al.
Published: (2025-01-01)

Correlation between <i>PPARG</i> Pro12Ala Polymorphism and Therapeutic Responses to Thiazolidinediones in Patients with Type 2 Diabetes: A Meta-Analysis
by: Eun Jeong Jang, et al.
Published: (2023-06-01)

TRIB3 suppresses milk fatty acids metabolism by inhibiting p‐AKT/PPARG signaling in goat mammary epithelial cells
by: Xinglong Gong, et al.
Published: (2025-08-01)

PPARG activation promotes the proliferation of colorectal cancer cell lines and enhances the antiproliferative effect of 5-fluorouracil
by: Leah Schöckel, et al.
Published: (2024-02-01)

Aaptamine Inhibits Lipid Accumulation and Pparg and Slc2a4 Expression While Maintaining the Methylation of the Pparg Promoter During 3T3-L1 Adipocyte Differentiation
by: Ariyanto EF, et al.
Published: (2025-03-01)

THE PPARG RECEPTOR AGONIST PIOGLITAZONE REDUCES PULMONARY FIBROSIS INDUCED BY BLEOMYCIN ADMINISTRATION IN MICE
by: A.V. Kabaliei, et al.
Published: (2024-12-01)

PPARG in osteocytes controls cell bioenergetics and systemic energy metabolism independently of sclerostin levels in circulation
by: Sudipta Baroi, et al.
Published: (2024-10-01)

Honokiol Ameliorates Hepatic Lipid Accumulation by Deacetylating PPARG via SIRT3
by: Yantao Yang, et al.
Published: (2026-06-01)

PPARG stimulation restored lung mRNA expression of core clock, inflammation‐ and metabolism‐related genes disrupted by reversed feeding in male mice
by: Oksana Shlykova, et al.
Published: (2023-09-01)

Expression Analysis of circRNAs in Human Adipogenesis
by: Yi X, et al.
Published: (2024-01-01)

Generation of human TMEM16F-specific affibodies using purified TMEM16F
by: Eunyoung Kim, et al.
Published: (2024-01-01)

Nobiletin alleviates atherosclerosis by inhibiting lipid uptake via the PPARG/CD36 pathway
by: Heng Wang, et al.
Published: (2024-03-01)

Genotype-based recall to study metabolic effects of genetic variation: a pilot study of PPARG Pro12Ala carriers
by: Prasad G. Kamble, et al.
Published: (2017-10-01)

Transmembrane protein TMEM98 as a multifunctional regulator in cancer: from signaling pathways to translational implications
by: Xiaoling Xu, et al.
Published: (2025-09-01)

PPARG agonist pioglitazone influences diurnal kidney medulla mRNA expression of core clock, inflammation‐, and metabolism‐related genes disrupted by reverse feeding in mice
by: Olga Izmailova, et al.
Published: (2022-12-01)

Integrated investigation and experimental validation of PPARG as an oncogenic driver: implications for prognostic assessment and therapeutic targeting in hepatocellular carcinoma
by: Yunsheng Ran, et al.
Published: (2023-11-01)

Circular RNA encoded by PPARG in the peripheral blood and a lipopolysaccharide-induced cardiomyocyte inflammation model is identified as a marker of fulminant myocarditis
by: Shasha Huang, et al.
Published: (2025-02-01)

PPARG genindeki Pro12Ala polimorfizmi, Türk populasyonunda insülin direnci ve tip 2 diyabet ile ilişkili değildir: Bir vaka-kontrol çalışması
by: Süleyman Baldane, et al.
Published: (2021-12-01)

Association of PPARG genotypes with biochemical markers in type 2 diabetes mellitus among a Nigerian population
by: David Olufemi Adebo, et al.
Published: (2024-12-01)

Glucocorticoid receptor inhibits Th2 immune responses by down-regulating Pparg and Gata3 in schistosomiasis
by: Tao Sun, et al.
Published: (2025-03-01)

Milestones in Molecular Mechanisms of Adipogenesis and Adipose Tissue Plasticity
by: Olga P. Shatova, et al.
Published: (2021-09-01)

Comprehensive analysis of TMEM9 in human tumors
by: Xuezhong Zhang, et al.
Published: (2025-03-01)